Magnetic resonance imaging for liver cirrhosis using functionalized contrast agent

Teruhiko Shigeoka; Masaharu Murata; Shohei Yamaguti; Takeshi Mori; Takuro Niidome; Yoshiki Katayama; Makoto Hashizume

Magnetic resonance imaging for liver cirrhosis using functionalized contrast agent

Teruhiko Shigeoka, Masaharu Murata, Shohei Yamaguti, Takeshi Mori, Takuro Niidome, Yoshiki Katayama, Makoto Hashizume

先端医療医学

研究成果: 会議への寄与タイプ › 学会誌 › 査読

抄録

Advances in molecular imaging provide new insights into the pathophysiology of many diseases. In this research, we have development functional molecule for MRI contrast agent of the liver. The agent, LAC-DOTA, is expected accumulation into hepatocytes. The molecular imaging ability of LAC-DOTA was measured by measuring the liver imaging ability of a normal mouse and a liver cirrhosis mouse. The LAC-DOTA enhanced MRI imaging may be emerged as a promising modality for detection and diagnosis of liver cirrhosis.

本文言語	英語
ページ数	1
出版ステータス	出版済み - 10月 19 2006
イベント	55th SPSJ Annual Meeting - Nagoya, 日本継続期間: 5月 24 2006 → 5月 26 2006

その他

その他	55th SPSJ Annual Meeting
国/地域	日本
City	Nagoya
Period	5/24/06 → 5/26/06

!!!All Science Journal Classification (ASJC) codes

工学（全般）

他のファイルとリンク

引用スタイル

@conference{934fadb7141442edad803d75ee5925e3,

title = "Magnetic resonance imaging for liver cirrhosis using functionalized contrast agent",

abstract = "Advances in molecular imaging provide new insights into the pathophysiology of many diseases. In this research, we have development functional molecule for MRI contrast agent of the liver. The agent, LAC-DOTA, is expected accumulation into hepatocytes. The molecular imaging ability of LAC-DOTA was measured by measuring the liver imaging ability of a normal mouse and a liver cirrhosis mouse. The LAC-DOTA enhanced MRI imaging may be emerged as a promising modality for detection and diagnosis of liver cirrhosis.",

author = "Teruhiko Shigeoka and Masaharu Murata and Shohei Yamaguti and Takeshi Mori and Takuro Niidome and Yoshiki Katayama and Makoto Hashizume",

year = "2006",

month = oct,

day = "19",

language = "English",

note = "55th SPSJ Annual Meeting ; Conference date: 24-05-2006 Through 26-05-2006",

}

TY - CONF

T1 - Magnetic resonance imaging for liver cirrhosis using functionalized contrast agent

AU - Shigeoka, Teruhiko

AU - Murata, Masaharu

AU - Yamaguti, Shohei

AU - Mori, Takeshi

AU - Niidome, Takuro

AU - Katayama, Yoshiki

AU - Hashizume, Makoto

PY - 2006/10/19

Y1 - 2006/10/19

N2 - Advances in molecular imaging provide new insights into the pathophysiology of many diseases. In this research, we have development functional molecule for MRI contrast agent of the liver. The agent, LAC-DOTA, is expected accumulation into hepatocytes. The molecular imaging ability of LAC-DOTA was measured by measuring the liver imaging ability of a normal mouse and a liver cirrhosis mouse. The LAC-DOTA enhanced MRI imaging may be emerged as a promising modality for detection and diagnosis of liver cirrhosis.

AB - Advances in molecular imaging provide new insights into the pathophysiology of many diseases. In this research, we have development functional molecule for MRI contrast agent of the liver. The agent, LAC-DOTA, is expected accumulation into hepatocytes. The molecular imaging ability of LAC-DOTA was measured by measuring the liver imaging ability of a normal mouse and a liver cirrhosis mouse. The LAC-DOTA enhanced MRI imaging may be emerged as a promising modality for detection and diagnosis of liver cirrhosis.

UR - http://www.scopus.com/inward/record.url?scp=33749845906&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749845906&partnerID=8YFLogxK

M3 - Paper

AN - SCOPUS:33749845906

T2 - 55th SPSJ Annual Meeting

Y2 - 24 May 2006 through 26 May 2006

ER -

Magnetic resonance imaging for liver cirrhosis using functionalized contrast agent

抄録

その他

!!!All Science Journal Classification (ASJC) codes

他のファイルとリンク

フィンガープリント

引用スタイル